Literature DB >> 33360821

Prosthesis embodiment and attenuation of prosthetic touch in upper limb amputees - A proof-of-concept study.

Antonia Fritsch1, Bigna Lenggenhager2, Robin Bekrater-Bodmann3.   

Abstract

Sensory attenuation of self-touch, that is, the perceptual reduction of self-generated tactile stimuli, is considered a neurocognitive basis for self-other distinction. However, whether this effect can also be found in upper limb amputees using a prosthesis is unknown. Thirteen participants were asked to touch their foot sole with a) their intact hand (self-touch), b) their prosthesis (prosthesis-touch), or c) let it be touched by another person (other-touch). Intensity of touch was assessed with a questionnaire. In addition, prosthesis embodiment was assessed in nine participants. Self-touch as well as prosthesis-touch was characterized by significant perceptual attenuation compared to other-touch, while self- and prosthesis-touch did not differ. The more embodied the prosthesis was, the more similar was its elicited touch perception to actual self-touch. These findings - although preliminary - suggest that perceptually embodied prostheses can be represented as an actual limb by the users' sensorimotor system.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Embodiment; Forward model; Prosthesis; Self-touch; Sensory attenuation

Year:  2020        PMID: 33360821     DOI: 10.1016/j.concog.2020.103073

Source DB:  PubMed          Journal:  Conscious Cogn        ISSN: 1053-8100


  2 in total

1.  Impact of Shared Control Modalities on Performance and Usability of Semi-autonomous Prostheses.

Authors:  Jérémy Mouchoux; Miguel A Bravo-Cabrera; Strahinja Dosen; Arndt F Schilling; Marko Markovic
Journal:  Front Neurorobot       Date:  2021-12-17       Impact factor: 2.650

Review 2.  Prosthetic embodiment: systematic review on definitions, measures, and experimental paradigms.

Authors:  Jan Zbinden; Eva Lendaro; Max Ortiz-Catalan
Journal:  J Neuroeng Rehabil       Date:  2022-03-28       Impact factor: 4.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.